Methyl-Substituted Conformationally Constrained Rexinoid Agonists for the Retinoid X Receptors Demonstrate Improved Efficacy for Cancer Therapy and Prevention

Bioorganic and Medicinal Chemistry - United Kingdom
doi 10.1016/j.bmc.2013.11.039

Related search